Newsletter
Every new paper in this field, in your inbox.
A retrospective analysis of over 57,000 patients with stage II to III esophageal cancer revealed that both perioperative chemotherapy and trimodality therapy significantly enhance overall survival compared to definitive chemoradiation therapy (DCRT). Perioperative chemotherapy showed a median overall survival of 66.2 months, while trimodality therapy…
A comprehensive analysis of 68,755 patients indicates that robotic gastrectomy (rg) offers superior outcomes compared to laparoscopic gastrectomy (lg) in gastric cancer treatment. Key benefits of rg include increased lymph node retrieval, reduced intraoperative blood loss, shorter hospital stays, and faster recovery metrics, such as…
A new predictive model, combining small ribonucleic acids (srnas) and clinical factors, shows promise in forecasting pathologic complete response (pcr) in esophageal squamous cell carcinoma post-neoadjuvant chemoradiotherapy. Among 99 patients, significant predictors included isomirs of let-7b and mir-93, plus specific clinical indicators. The model achieved…
In a study involving 450 achalasia patients undergoing peroral endoscopic myotomy (POEM), treatment outcomes were favorable across disease types, with efficacy rates of 97.9% and 94.2% at one and two years, respectively. However, the incidence of esophageal cancer varied significantly among types: 1% in straight,…
A significant increase in the utilization of neoadjuvant therapies, particularly neoadjuvant chemotherapy (NAC) and neoadjuvant chemoradiotherapy (NCRT), was observed from 2012 to 2017 among gastric adenocarcinoma patients. The analysis included 25,073 patients, revealing median overall survival rates of 51.0 months for those receiving neoadjuvant therapy…
A predictive model utilizing tumor-stroma percentage (tsp) in gastric cancer (gc) demonstrated its significance as an adverse prognostic factor for overall survival (OS). Among 872 gc patients, tsp-visual showed a hazard ratio of 2.042, indicating a correlation with advanced pathological staging. The developed nomogram effectively…
Evidence suggests that surgical intervention, prior to peptide receptor radionuclide therapy, significantly enhances progression-free survival for patients with metastatic gastroenteropancreatic neuroendocrine tumors. In a study of 89 well-matched patients, those who underwent surgery had a median progression-free survival of 26.1 months, compared to 15.6 months…
The lymph node ratio (LNR) has been identified as a crucial prognostic factor in patients with postoperative duodenal adenocarcinoma. In a study involving 943 patients, those with an LNR of 0.12 or greater experienced poorer overall survival. A nomogram integrating key prognostic factors, including LNR…
A patient-specific vascular navigation system demonstrated clinical feasibility in laparoscopic gastrectomy for gastric cancer, with no adverse events reported during surgeries. Compared to 114 patients without the system, those using it had significantly lower overall complication rates (10.5% vs. 26.3%, p=0.043) and no pancreas-related complications…
A meta-analysis of 12 randomized controlled trials involving 1,181 gastric cancer patients demonstrated that hyperthermic intraperitoneal chemotherapy (HIPEC) significantly improved survival rates compared to control groups at 1, 2, 3, and 5 years. The recurrence rates were notably lower in the HIPEC group, and higher…
